TriSalus Life Sciences, Inc. (TLSI)
(Delayed Data from NSDQ)
$4.90 USD
-0.02 (-0.41%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $4.87 -0.03 (-0.61%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, TriSalus Life Sciences, Inc. has a market cap of $245.35M, which represents its share price of $4.92 multiplied by its outstanding shares number of 49.87M. As a small-cap company, TLSI's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TLSI 4.90 -0.02(-0.41%)
Will TLSI be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TLSI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TLSI
TriSalus Life Sciences, Inc. (TLSI) Reports Q2 Loss, Tops Revenue Estimates
Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates
TLSI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zimmer Biomet (ZBH) Beats Q2 Earnings and Revenue Estimates
TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates
OrganiGram (OGI) Reports Q2 Loss, Beats Revenue Estimates (Revised)
Other News for TLSI
Is TLSI preparing to trend lower? 20 Day Moving Average Resistance shows up after dropping 0.41%
Is TLSI preparing to trend higher? Directional Movement Crossover Bullish shows up after rising 2.5%
TLSI forms Pocket Pivot on September 17
TLSI Crossed Above 50 Day Moving Average on September 16
50 Day Moving Average Resistance appears for TLSI after 3.84% move